Trilantic Europe has sold Dietopack to DENTRESSANGLE Capital, who aims to integrate it with Naturacare to create a leading international player in the nutraceutical sector.
Target Company Overview
Trilantic Europe, a distinguished pan-European private equity firm, has announced the sale of Dietopack S.r.l. (“Dietopack” or the “Company”) to DENTRESSANGLE Capital, a subsidiary of Norbert Dentressangle's investment holding company. Founded in 2000 in Medolla, Modena, Italy, Dietopack specializes in the manufacturing of nutraceutical and pet nutritional products, known for its exemplary production capabilities and industrial expertise. The Company produces a diverse range of products including liquids, tablets, granules, and capsules aimed at both human and pet consumers.
Industry Overview in Italy
The nutraceutical industry in Italy is experiencing substantial growth, spurred by an increasing focus on health and wellness among consumers. As health consciousness rises, there is a marked shift towards dietary supplements, particularly those that enhance health, wellness, and prevent diseases. Italy's unique positioning within the European Union, combined with a strong tradition of herbal and organic products, enhances its appeal in the nutraceutical sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Local regulations and a structured framework ensure the quality and efficacy of nutraceutical products. The Italian government supports innovation in the health and nutrition sector, encouraging researc
Similar Deals
HOFI SpA → San Siro
2023
Trilantic Europe → Doppel Farmaceutici
2023
Progressio Investimenti II fund and IDEA CAPITAL FUNDS → ITALCHIMICI S.p.a.
2023
CPF Living Communities → Rivertown Ridge
2025
DENTRESSANGLE Capital
invested in
Dietopack S.r.l.
in 2023
in a Management Buyout / Buy-In (MBO) deal